cgp 28392 has been researched along with darodipine in 1 studies
Studies (cgp 28392) | Trials (cgp 28392) | Recent Studies (post-2010) (cgp 28392) | Studies (darodipine) | Trials (darodipine) | Recent Studies (post-2010) (darodipine) |
---|---|---|---|---|---|
76 | 1 | 2 | 77 | 10 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hof, A; Hof, RP; Loutzenhiser, R; Rüegg, UT | 1 |
1 other study(ies) available for cgp 28392 and darodipine
Article | Year |
---|---|
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Male; Nifedipine; Potassium Chloride; Pyridines; Rabbits; Vasoconstriction; Vasoconstrictor Agents | 1984 |